842 research outputs found
Oxidation mechanism in metal nanoclusters: Zn nanoclusters to ZnO hollow nanoclusters
Zn nanoclusters (NCs) are deposited by Low-energy cluster beam deposition
technique. The mechanism of oxidation is studied by analysing their
compositional and morphological evolution over a long span of time (three
years) due to exposure to ambient atmosphere. It is concluded that the
mechanism proceeds in two steps. In the first step, the shell of ZnO forms over
Zn NCs rapidly up to certain limiting thickness: with in few days -- depending
upon the size -- Zn NCs are converted to Zn-ZnO (core-shell), Zn-void-ZnO, or
hollow ZnO type NCs. Bigger than ~15 nm become Zn-ZnO (core-shell) type: among
them, NCs above ~25 nm could able to retain their initial geometrical shapes
(namely triangular, hexagonal, rectangular and rhombohedral), but ~25 to 15 nm
size NCs become irregular or distorted geometrical shapes. NCs between ~15 to 5
nm become Zn-void-ZnO type, and smaller than ~5 nm become ZnO hollow sphere
type i.e. ZnO hollow NCs. In the second step, all Zn-void-ZnO and Zn-ZnO
(core-shell) structures are converted to hollow ZnO NCs in a slow and gradual
process, and the mechanism of conversion proceeds through expansion in size by
incorporating ZnO monomers inside the shell. The observed oxidation behaviour
of NCs is compared with theory of Cabrera - Mott on low-temperature oxidation
of metal.Comment: 9 pages, 8 figure
Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study
This randomized, open-label, active-controlled, dose-finding phase IIb study evaluated the efficacy and safety of trabedersen (AP 12009) administered intratumorally by convection-enhanced delivery compared with standard chemotherapy in patients with recurrent/refractory high-grade glioma. One hundred and forty-five patients with central reference histopathology of recurrent/refractory glioblastoma multiforme (GBM) or anaplastic astrocytoma (AA) were randomly assigned to receive trabedersen at doses of 10 or 80 µM or standard chemotherapy (temozolomide or procarbazine/lomustine/vincristine). Primary endpoint was 6-month tumor control rate, and secondary endpoints included response at further timepoints, survival, and safety. Six-month tumor control rates were not significantly different in the entire study population (AA and GBM). Prespecified AA subgroup analysis showed a significant benefit regarding the 14-month tumor control rate for 10 µM trabedersen vs chemotherapy (p= .0032). The 2-year survival rate had a trend for superiority for 10 µM trabedersen vs chemotherapy (p = .10). Median survival for 10 µM trabedersen was 39.1 months compared with 35.2 months for 80 µM trabedersen and 21.7 months for chemotherapy (not significant). In GBM patients, response and survival results were comparable among the 3 arms. Exploratory analysis on GBM patients aged ≤55 years with Karnofsky performance status >80% at baseline indicated a 3-fold survival at 2 and 3 years for 10 µM trabedersen vs chemotherapy. The frequency of patients with related or possibly drug-related adverse events was higher with standard chemotherapy (64%) than with 80 µM trabedersen (43%) and 10 µM trabedersen (27%). Superior efficacy and safety for 10 µM trabedersen over 80 µM trabedersen and chemotherapy and positive risk–benefit assessment suggest it as the optimal dose for further clinical development in high-grade glioma
De Sitter vacua from N=2 gauged supergravity
Typical de Sitter (dS) vacua of gauged supergravity correspond to saddle
points of the potential and often the unstable mode runs into a singularity. We
explore the possibility to obtain dS points where the unstable mode goes on
both sides into a supersymmetric smooth vacuum. Within N=2 gauged supergravity
coupled to the universal hypermultiplet, we have found a potential which has
two supersymmetric minima (one of them can be flat) and these are connected by
a de Sitter saddle point. In order to obtain this potential by an Abelian
gauging, it was important to include the recently proposed quantum corrections
to the universal hypermultiplet sector. Our results apply to four as well as
five dimensional gauged supergravity theories.Comment: 25 pages, 1 figure, add refs and corrected typo
Anatomical considerations and emerging strategies for reducing new onset conduction disturbances in percutaneous structural heart disease interventions
Transcatheter procedures offer an alternative to cardiac surgery in select patients with structural heart disease (SHD). Unfortunately, inadvertent disruption of electrical pathways and subsequent development of new onset conduction disturbances can occur in up to 5–70% of percutaneous interventions, result in pacemaker implantation, and confer a worse prognosis. The physical proximity between the conduction system (atrioventricular node, bundle of His, and bundle branches) and the site of percutaneous repair is increasingly recognized as a key factor influencing new onset conduction disturbance development in procedures located near the conduction system. This review covers the incidence, clinical significance, and mechanisms of new onset conduction disturbances and discusses current and emerging strategies to address this complication in these populations
Small-scale cosmic ray anisotropy observed by the GRAPES-3 experiment at TeV energies
GRAPES-3 is a mid-altitude (2200 m) and near equatorial (
North) air shower array, overlapping in its field of view for cosmic ray
observations with experiments that are located in Northern and Southern
hemispheres. We analyze a sample of cosmic ray events collected
by the GRAPES-3 experiment between 1 January 2013 and 31 December 2016 with a
median energy of TeV for study of small-scale () angular
scale anisotropies. We observed two structures labeled as A and B, deviate from
the expected isotropic distribution of cosmic rays in a statistically
significant manner. Structure `A' spans to in the
right ascension and to in the declination
coordinate. The relative excess observed in the structure A is at the level of
with a statistical significance of 6.8 standard
deviations. Structure `B' is observed in the right ascension range of
to . The relative excess observed in this region is
at the level of with a statistical significance of
4.7 standard deviations. These structures are consistent with those reported by
Milagro, ARGO-YBJ, and HAWC. These observations could provide a better
understanding of the cosmic ray sources, propagation and the magnetic
structures in our Galaxy
Centrality Dependence of Neutral Pion Production in 158 A GeV Pb + Pb Collisions
The production of neutral pions in 158AGeV Pb+Pb collisions has been studied
in the WA98 experiment at the CERN SPS. Transverse momentum spectra are studied
for the range 0.3 GeV/c < mT-m0 < 4.0 GeV/c. The results for central collisions
are compared to various models. The centrality dependence of the neutral pion
spectral shape and yield is investigated. An invariance of the spectral shape
and a simple scaling of the yield with the number of participating nucleons is
observed for centralities with greater than about 30 participating nucleons
which is most naturally explained by assuming an equilibrated system.Comment: 5 pages, Latex, including 3 eps figures, submitted to Phys.Rev.Lett;
updated pQCD comparison due to new input from the author, updated references,
corrected plotting error in figure
Resonant Structure of and Decays
The resonant structure of the four pion final state in the decay is analyzed using 4.27 million pairs
collected by the CLEO II experiment. We search for second class currents in the
decay using spin-parity analysis and establish an
upper limit on the non-vector current contribution. The mass and width of the
resonance are extracted from a fit to the
spectral function. A partial wave analysis of the resonant structure of the
decay is performed; the spectral decomposition of
the four pion system is dominated by the and final
states.Comment: 34 pages postscript, also available through
http://w4.lns.cornell.edu/public/CLN
Search for a Scalar Bottom Quark with Mass 3.5-4.5 GeV/
We report on a search for a supersymmetric meson with mass
between 3.5 and 4.5 GeV/ using 4.52 of integrated
luminosity produced at GeV, just below the threshold, and collected with the CLEO detector. We find no evidence
for a light scalar bottom quark.Comment: 10 pages postscript, also available through
http://w4.lns.cornell.edu/public/CLN
- …